Innovative Technology Immunolight's breakthrough platform that converts energy across the electromagnetic spectrum presents opportunities to collaborate with medical device and imaging companies seeking advanced energy transfer solutions.

Recognition and Credibility Being named Crain’s Detroit Business News Most Innovative Company in 2016 enhances the company's credibility and can open doors to partnerships within the biotech and medical research industries.

Market Potential With revenue estimates between one and ten million dollars and expertise in transforming low dose X-ray energy, Immunolight is positioned to serve niche markets requiring innovative energy manipulation technologies.

Research Focus Their focus on activating natural compounds with energy conversion creates opportunities to partner with pharmaceutical companies and medical researchers looking to develop novel therapies.

Targeted Engagement Focusing outreach on biotech firms, medical device manufacturers, and research institutions involved in energy-based therapies can unlock strategic collaborations and sales growth for Immunolight.